Patent Granted for Simbionix Procedure Rehearsal Studio(TM)

CLEVELAND, Ohio, August 10, 2011 /PRNewswire/ –

Simbionix USA Corporation, the world’s leading provider of medical
simulation training and education products for medical professionals and the
healthcare industry, is pleased to announce it has been granted a patent in
the UK for its innovative PROcedure Rehearsal Studio(TM).

The PROcedure Rehearsal Studio(TM)
[http://simbionix.com/clinical-rehearsal ] is a first in industry product,
allowing clinicians to create patient specific 3D and 4D anatomical models
based on a patient’s imaging data, such as CT, for the purpose of simulating
and planning endovascular procedures. The patent was granted on Simbionix’s
proprietary technology used in order to simulate an image guided angioplasty
procedure based on input from a patient’s 3D medical image, allowing a
hands-on planning and rehearsal experience as well as providing physicians
with unlimited generation of unique clinical case studies and the ability to
better demonstrate a complex clinical procedure to their patients.

Earlier this year, the PROcedure Rehearsal Studio(TM) software was
market cleared
[http://simbionix.com/2010/09/29/simbionix-receives-fda-clearance-to-take-medical-simulation-technology-one-step-further-into-clinical-settings/#more-153 ]
in the United States, intended for use as a software interface and image
segmentation system for the transfer of imaging data from a medical scanner
to an output file. It is also intended as pre-operative software for
simulating and evaluating surgical treatment options. Unique to the
Simbionix simulation systems, the 3D segmentation model can be exported to
the Simbionix ANGIO Mentor(TM) Simulator
[http://simbionix.com/simulators/angio-mentor ] practice environment. The
results are an advanced method of creating an ever expanding library of
modules for training and post-operative debriefing.

“This addition to the company’s comprehensive IP portfolio is evidence
to the uniqueness and quality of Simbionix’s products and exceptional
development team,” said Simbionix CFO, Mr. Boaz Tal. “Technologically
advanced medical education solutions are becoming more accepted and are
regularly integrated into medical training programs. The patented PROcedure
Rehearsal Studio(TM) allows for the integration of medical imaging into
training, stregthening the link between the clinical and training. Having
been granted the patent is an additional sign of recognition for the
Simbionix comprehensive line of products, which provide innovative solutions
to advance medical performance and ensure patient safety.”

About Simbionix USA Corporation

Simbionix is the world’s leading provider of simulation and training
products for medical professionals and the healthcare industry. Founded in
1997, the company is committed to delivering high quality products,
advancing clinical performance and optimizing procedural outcomes.

For more information on Simbionix, visit http://www.simbionix.com

Contact: Rebecca Zitter, +1-216-229-2040 – ext. 128,
rebecca@simbionix.com

SOURCE Simbionix USA Corporation